Department of Nursing, University of Seville, 41009 Seville, Spain.
Faculty of Nursing, Physiotherapy and Podiatry, University of Seville, 41009 Seville, Spain.
Int J Environ Res Public Health. 2021 Jan 24;18(3):1017. doi: 10.3390/ijerph18031017.
According to the World Health Organization, cancer is the second leading cause of death in the world. In Spain, about a quarter of a million cases were diagnosed in 2017, and 81% of the Spanish population has used, at least once, some kind of complementary therapy. Said therapies are increasingly being used by cancer patients. The purpose of the study is to analyse the effectiveness of complementary therapies among cancer patients. A systematic peer review was conducted following the PRISMA-ScR guide in four databases (PubMed, CINAHL, Scopus and WOS). The inclusion criteria were Randomised Clinical Trials, published between 2013 and 2018, with a value of 3 or more on the Jadad Scale. The protocol was registered in PROSPERO (CRD42019127593). The study sample amounted to 1845 patients (64.55% women), the most common being breast cancer patients (794), followed by lung cancer patients (341). Fifteen complementary therapies were identified. We found two studies for each of the following: electroacupuncture, phytotherapy, hypnotherapy, guided imagery and progressive muscle relaxation. From the remaining ones, we identified a study on each therapy. The findings reveal some effective complementary therapies: auriculotherapy and acupuncture, laser moxibustion, hypnosis, Ayurveda, electroacupuncture, progressive muscle relaxation and guided imagery, yoga, phytotherapy, music therapy and traditional Chinese medicine. On the other hand, electroacupuncture, laser moxibustion and traditional Chinese medicine presented adverse effects, and kinesiology did not show effectiveness.
根据世界卫生组织的数据，癌症是全球第二大致死原因。2017 年，在西班牙诊断出约 25 万例病例，81%的西班牙人口至少使用过一次某种补充疗法。这些疗法越来越多地被癌症患者使用。本研究旨在分析补充疗法在癌症患者中的有效性。我们按照 PRISMA-ScR 指南在四个数据库（PubMed、CINAHL、Scopus 和 WOS）中进行了系统的同行评审。纳入标准为 2013 年至 2018 年期间发表的随机临床试验，Jadad 量表评分为 3 或以上。该方案已在 PROSPERO（CRD42019127593）中注册。研究样本共计 1845 名患者（64.55%为女性），最常见的是乳腺癌患者（794 名），其次是肺癌患者（341 名）。共确定了 15 种补充疗法。我们发现有两项研究针对以下每种疗法：电针、植物疗法、催眠疗法、引导意象和渐进性肌肉松弛。在其余的疗法中，我们针对每种疗法都找到了一项研究。研究结果显示了一些有效的补充疗法：耳针和针刺、激光灸、催眠、阿育吠陀、电针、渐进性肌肉松弛和引导意象、瑜伽、植物疗法、音乐疗法和中医。另一方面，电针、激光灸和中医有不良反应，运动疗法则没有效果。
